Emergency guidelines
SfE Emergency Guidance for Hypocalcaemia & Hypercalcaemia
Emergency Guidance for Acute Hypocalaemia
Emergency Guidance for Acute Hypercalcaemia
COVID guidelines
COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
Endocrine, M. Puig-Domingo, M. Marazuela, B.Yildiz, A.Giustina April 2021
Society for Endocrinology Planning & recommendations for COVID-19 second wave
* Prioritise severe or symptomatic hypercalcaemia and hypocalcaemia
Endocrinology in the time of Covid-19: Management of calcium metabolic disorders and osteoporosis
EJE bioscientifica, Gittoes et al, May 2020
Society for Endocrinology (SfE) COVID-19 resources for managing endocrine conditions
Coronavirus and parathyroid conditions FAQs
Template letter to give to your patients with hypoparathyroidism
Hypopara Guidelines
European Society for Endocrinology(ESE) Clinical Guideline: Treatment of Chronic Hypoparathyroidism in Adults
Bollerslev et al, EJE 173:2 July 2015
Management of Hypoparathyroidism: Summary Statement and Guidelines
JCEM Volume 101, Issue 6, 1 June 2016, 2273–2283
Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus
Aliya A Khan et al, EJE Vol 190 Issue 3 p1-22 March 2019
BAETS Post Thyroidectomy Hypocalcaemia Guidelines
Data from the UK Registry of Endocrine and Thyroid Surgery (www.baets.org.uk/audit) shows that post thyroidectomy hypocalcaemia rates can reach 27%.
Read the BAETS Post op hypocalcaemia management guidance here
Hyperpara Guidelines
NICE guidelines on Primary Hyperparathyroidism
Nice guideline (NG132) 23rd May 2019
Parathyroid UK helped to develop this guideline which covers diagnosing, assessing and managing primary hyperparathyroidism. It aims to improve recognition and treatment of this condition, reducing long‑term complications and improving quality of life.